MedMira's market success in the United States, Canada and China has come from a broad acceptance of the performance of its products by clinical laboratory professionals. All of MedMira's products are based on the same unique flow-through membrane technology, which relies on highly specific antigen-antibody reactions allowing for the detection of disease-specific markers in clinical specimens. In our rapid tests, a special membrane is coated with disease-specific antigens or antibodies to capture the corresponding marker in the test sample, thus allowing for the detection of the disease. The simple testing procedure involves placing a drop of the test sample on the coated test membrane and allowing it to flow through the membrane. If the sample contains the target antibodies or antigens, they are captured on the test membrane and result in a highly specific antigen-antibody complex. The test result is visualized at a colored end point through a reaction with a proprietary detection agent and can be interpreted immediately.

MedMira deploys its distinctive flow-through testing platform; including a single buffer solution for preparation and performance of the test and unique colorimetric agent, which allows for a visual interpretation of test results. The testing procedure is completed within 3 minutes. Precision pipetting, sample manipulation or specialized equipment is not required to perform any of MedMira's rapid tests, making it an invaluable diagnostic resource in laboratories that are space and time limited.


One Platform, Multiple Applications

MedMira's market-proven, flow-through membrane technology platform can be used quickly and efficiently to develop tests for many diseases, from smallpox to emerging diseases such as avian influenza. MedMira develops disease-specific rapid tests based on its proprietary technology, making all test procedures similarly simple and user-friendly. As a result, MedMira is able to develop and market reliable, high-quality tests for other diseases quickly, and ensure ready acceptance and use by medical laboratories.

MedMira's rapid tests are ideal for use in hospital and medical diagnostic laboratories, medical clinics and doctor's offices. Offering results within just a few minutes, MedMira's tests are highly suitable for use in such emergency situations such as occupational exposures, and labor and delivery. MedMira's rapid tests are also particularly appealing for general use in settings with limited resources or time constraints. Since results are available immediately, rapid tests will improve the delivery of medical care and prevention efforts with substantial time and cost savings.

            

Disclaimer: The public should be aware that the sale of MedMira's products is controlled by the governing regulatory agencies in specific regions. Therefore, please be advised that certain statements on this website do not apply to all MedMira products. Specifically, in a growing number of countries MedMira's products are allowed and/or approved for sale in medical settings, point-of-care, and for home use. Details on each product's situation can be obtained from MedMira and/or its distributors.